Loading clinical trials...
Loading clinical trials...
This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Eirion Therapeutics Inc.
NCT04818203 · Crow's Feet
NCT04985916 · Lateral Canthal Lines, LCL, Crow's Feet
NCT04157686 · Glabellar Lines, Lateral Canthal Lines
NCT06402058 · Crow's Feet Lines
NCT06376838 · Crow's Feet Lines
Baumann Cosmetic & Research Institute
Miami, Florida
Radiant Research, Inc.
Pinellas Park, Florida
Research Institute of the Southeast, LLC
West Palm Beach, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions